CA
TWST icon

Crewe Advisors’s Twist Bioscience TWST Stock Holding History

Crewe Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$309 Hold
3
– – ﹤0.01% 1095
2026
Q1 		$143 Hold
3
– – ﹤0.01% 1010
2025
Q4 		$96 Hold
3
– – ﹤0.01% 1075
2025
Q3 		$85 Hold
3
– – ﹤0.01% 952
2025
Q2 		$111 Buy
+3
New +$104 ﹤0.01% 729
2024
Q2 		– Sell
-110
Closed -$3.77K – 1041
2024
Q1 		$3.77K Buy
+110
New +$3.97K ﹤0.01% 780
2022
Q4 		– Sell
-123
Closed -$4K – 1274
2022
Q3 		$4K Buy
123
+40
+48% +$1.7K ﹤0.01% 915
2022
Q2 		$3K Buy
+83
New +$2.94K ﹤0.01% 929

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Crewe Advisors's TWST Position: Q2 2026 in Review

Crewe Advisors held its Twist Bioscience (TWST) position steady in Q2 2026 at 3 shares worth $309. The position accounts for ﹤0.01% of the portfolio, ranked #1095.

Crewe Advisors first reported a position in TWST in Q2 2022 and has held it in 8 quarters since. The position peaked at $4K in Q3 2022. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Crewe Advisors held 3 shares of Twist Bioscience worth $309 as of Q2 2026.
  • Crewe Advisors left its Twist Bioscience share count unchanged in Q2 2026.
  • Twist Bioscience made up ﹤0.01% of Crewe Advisors's portfolio in Q2 2026, its #1095 holding.
  • Crewe Advisors first reported a position in Twist Bioscience in Q2 2022 and has held it in 8 quarters since.
  • Crewe Advisors's Twist Bioscience position peaked at $4K in Q3 2022.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.